“The arrival of this unprecedented ‘alien’ life form could in time have far-reaching ethical, legal and regulatory implications,”
Scientists reported Wednesday that they had taken a significant step toward altering the fundamental alphabet of life — creating an organism with an expanded artificial genetic code in its DNA.
The accomplishment might eventually lead to organisms that can make medicines or industrial products that cells with only the natural genetic code cannot.
The scientists behind the work at the Scripps Research Institute have already formed a company to try to use the technique to develop new antibiotics, vaccines and other products, though a lot more work needs to be done before this is practical.
The work also gives some support to the concept that life can exist elsewhere in the universe using genetics different from those on Earth.
“This is the first time that you have had a living cell manage an alien genetic alphabet,” said Steven A. Benner, a researcher in the field at the Foundation for Applied Molecular Evolution in Gainesville, Fla., who was not involved in the new work.
But the research, published online by the journal Nature, is bound to raise safety concerns and questions about whether humans are playing God. The new paper could intensify calls for greater regulation of the budding field known as synthetic biology, which involves the creation of biological systems intended for specific purposes.
“The arrival of this unprecedented ‘alien’ life form could in time have far-reaching ethical, legal and regulatory implications,” Jim Thomas of the ETC Group, a Canadian advocacy organization, said in an email. “While synthetic biologists invent new ways to monkey with the fundamentals of life, governments haven’t even been able to cobble together the basics of oversight, assessment or regulation for this surging field.”
Despite the great diversity of life on Earth, all species, from simple bacteria to human beings, use the same genetic code. It consists of four chemical units in DNA, sometimes called nucleotides or bases, that are usually represented by the letters A, C, G and T. The sequence of these chemical units determines what proteins the cell makes. Those proteins in turn do most of the work in cells and are required for the structure, function and regulation of the body’s tissues and organs.
The Scripps researchers chemically created two new nucleotides, which they called X and Y. They inserted an X-Y pair into the common bacterium E. coli. The bacteria were able to reproduce normally, though a bit more slowly than usual, replicating the X and Y along with the natural nucleotides.
In effect, the bacteria have a genetic code of six letters rather than four, perhaps allowing them to make novel proteins that could function in a completely different way from those created naturally.
“If you have a language that has a certain number of letters, you want to add letters so you can write more words and tell more stories,” said Floyd E. Romesberg, a chemist at Scripps who led the work.
Dr. Romesberg dismissed concern that novel organisms would run amok and cause harm, saying the technique was safe because the synthetic nucleotides were fed to the bacteria. Should the bacteria escape into the environment or enter someone’s body, they would not be able to obtain the needed synthetic material and would either die or revert to using only natural DNA.
The Latest on: Synthetic biology
[google_news title=”” keyword=”Synthetic biology” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Synthetic biology
- Call for Proposals: A Policy Toolkit on Developing International Guidelines on Engineering Biology at Higher Education Levelon May 16, 2024 at 5:00 pm
There are significant barriers to the application of synthetic biology that will have to be overcome before its full potential is realized. Some of these barriers include infrastructure development ...
- Zymergen nears final chapter with Bankruptcy Court settlementon May 16, 2024 at 5:00 pm
Zymergen became primarily an arm's-length synthetic biology service provider to Ginkgo, according to a Bankruptcy Court filing in October. However, according to a declaration from Zymergen's senior ...
- 30 Under 30 Asia: The Founders Developing New Diagnosis Methods And Innovative Healthcare Deviceson May 15, 2024 at 2:12 pm
From diagnosing Parkinson’s to synthetic biology, this year’s Healthcare and Science listees are putting scientific research into practice.
- WPI Researcher Receives $1.2 Million Award to Determine How Environment Impacts Gene Expression in Bacteriaon May 15, 2024 at 12:40 pm
Worcester Polytechnic Institute (WPI) researcher Natalie Farny is launching a $1.2 million, five-year project that could advance the use of bacteria for environmental cleanups by determining how a ...
- Method accelerates the development of sustainable biomaterials from years to minuteson May 15, 2024 at 7:22 am
A study, published in Advanced Materials on May 6, 2024, led by VTT's researchers, introduces a transformative approach that integrates synthetic biology with advanced machine learning and ...
- Fermbox Bio launches its first product in its Synbio product pipeline: A cellulosic enzyme cocktail to transform agricultural waste into 2G ethanolon May 15, 2024 at 3:02 am
Fermbox Bio, a synthetic biology research and manufacturing company, announces the launch of EN3ZYME, a cutting-edge enzyme cocktail designed to enhance both the efficiency and cost-effectiveness of ...
- SBSTTA and SBI—Biodiversity Meetings Crucial for the Global South Beginon May 15, 2024 at 1:23 am
More than 1,400 delegates are present at two crucial meetings, where preserving the planet's biodiversity for the benefit of humanity is under discussion.
- Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japanon May 14, 2024 at 3:08 pm
Sojitz intends to use its extensive network to help Ginkgo foster business connections within the Japanese bioeconomy. TOKYO and BOSTON, /PRNewswire/ -- Sojitz, a lar ...
- Synthetic biology market to rise at a 25.6% CAGR until 2027on May 8, 2024 at 10:45 pm
The global market is expected to grow by $28.25m within the forecast period. The global synthetic biology market is projected to grow by $28.25m at a compound annual growth rate of more than 25.6% ...
- It shouldn’t be easy to buy synthetic DNA fragments to recreate the 1918 flu viruson May 8, 2024 at 1:30 am
The immense potential benefits of biotechnology are profoundly vulnerable to misuse. Better screening of synthetic DNA orders is a key barrier to bad actors.
via Bing News